Join
Live feed
·
PRReleasevia Quantisnow
Immunovant Inc. logo
Roivant Sciences Ltd. logo

Roivant Unveils Durability and Treatment-Free Six-month Remission Data with Potential to Change Treatment Paradigm for Uncontrolled Graves' Disease Patients

ByQuantisnow·Wall Street's wire, on your screen.
IMVT· Immunovant Inc.ROIV· Roivant Sciences Ltd.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track IMVT (Immunovant Inc.), ROIV (Roivant Sciences Ltd.) and more on Quantisnow.